Fast, transcription‑factor‑based iPSC differentiation products and services delivering scalable, functional iPSC‑derived cells, kits, and custom research services. Targets research institutions, pharmaceutical and biomedical organizations, enabling faster, lower‑cost access to relevant cells for human biology modeling and drug discovery even without prior iPSC experience.